James Healy bought $20.4M of Rapport Therapeutics stock
By AlphaYouPublished Form 4
HEALY JAMES
Reporting filer
James Healy reported buying 969,480 shares of Rapport Therapeutics, Inc. for about $20.4M ($21.00 a share on average). Form 4 filed Oct 30, 2026 lists 4 entries.
See the price move since this trade →
- Disclosed
- Oct 30, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | HEALY JAMES | 2026-10-28 | P | Purchase | 952380 | 21.00 | 2,815,707 | 2 days | Filed terms
|
| Common Stock | HEALY JAMES | 2026-10-28 | P | Purchase | 6395 | 21.00 | 17,990 | 2 days | Filed terms
|
| Common Stock | HEALY JAMES | 2026-10-28 | P | Purchase | 3772 | 21.00 | 14,924 | 2 days | Filed terms
|
| Common Stock | HEALY JAMES | 2026-10-28 | P | Purchase | 6933 | 21.00 | 25,267 | 2 days | Filed terms
|
Common Stock
- Owner
- HEALY JAMES
- Date
- 2026-10-28
- Code
- P
- Action
- Purchase
- Quantity
- 952380
- Price
- 21.00
- Following holdings
- 2,815,707
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 952380
- transaction Price Per Share: 21.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 2815707
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sofinnova Venture Partners XI, L.P.
- id: F1
Common Stock
- Owner
- HEALY JAMES
- Date
- 2026-10-28
- Code
- P
- Action
- Purchase
- Quantity
- 6395
- Price
- 21.00
- Following holdings
- 17,990
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 6395
- transaction Price Per Share: 21.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 17990
- direct Or Indirect Ownership: I
- nature Of Ownership: By SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3
- id: F2
Common Stock
- Owner
- HEALY JAMES
- Date
- 2026-10-28
- Code
- P
- Action
- Purchase
- Quantity
- 3772
- Price
- 21.00
- Following holdings
- 14,924
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 3772
- transaction Price Per Share: 21.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 14924
- direct Or Indirect Ownership: I
- nature Of Ownership: By SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3
- id: F3
Common Stock
- Owner
- HEALY JAMES
- Date
- 2026-10-28
- Code
- P
- Action
- Purchase
- Quantity
- 6933
- Price
- 21.00
- Following holdings
- 25,267
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 6933
- transaction Price Per Share: 21.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 25267
- direct Or Indirect Ownership: I
- nature Of Ownership: By SummitTX Pinnacle Master, L.P. - Healthcare 3
- id: F4
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- HEALY JAMES: Director.
- F1: The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F2: The shares are directly held by SummitTX Master, SPC - SummitTX Apex SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - Crestline Summit Apex SP) ("Apex SP"). Sofinnova BioEquities GP LLC ("BioEquities GP") is the general partner of Apex SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Apex SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F3: The shares are directly held by SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - PEAK SP) ("Alpha SP"). BioEquities GP is the general partner of Alpha SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Alpha SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F4: The shares are directly held by SummitTX Pinnacle Master, L.P. - Healthcare 3 (f/k/a Crestline Summit Pinnacle Master, L.P.) ("Pinnacle LP"). BioEquities GP is the general partner of Pinnacle LP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Original sources
Prepared automatically from public filing data. Report a correction.